Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × HER-2 Negatived Gastric Cancer × S 1 (combination) × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4 Neoplasm Metastasis 4 Colorectal Neoplasms 4 HER-2 Negatived Gastric Cancer 1 Gastrointestinal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Advanced NSCLC With EGFR Mutation 1 Advanced Gastric Cancer 1 Advanced Gastric Adenocarcinoma 1

Interventions

apatinib 1 S 1 (combination) 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03950141 2019-05-15

Apatinib Combined With S-1 as Maintenance Therapy for HER-2 Negatived Gastric Cancer

Beijing Hospital

Phase 2 Unknown

Gastrointestinal

HER-2 Negatived Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡